Daily Archives: April 19, 2023
ACSM expert consensus statement on exertional heat illness: recognition, management, and return to activity
19 Apr, 2023 | 13:27h | UTCRelated:
Exertional heat stroke: pathophysiology and risk factors – BMJ Medicine
Classic and exertional heatstroke – Nature Reviews Disease Primers
Treatment and Prevention of Heat-Related Illness – New England Journal of Medicine
Joint statement for assessing and managing high blood pressure in children and adolescents
19 Apr, 2023 | 13:26h | UTCChapter 1: How to correctly measure blood pressure in children and adolescents – Frontiers in Pediatrics
Chapter 2: How to manage high blood pressure in children and adolescents – Frontiers in Pediatrics
Related:
AHA Scientific Statement | Pediatric primary hypertension: An underrecognized condition
AHA Scientific Statement: Ambulatory blood pressure monitoring in children and adolescents.
M-A | Glucocorticoids may increase mortality for hospitalized Covid-19 patients not receiving oxygen
19 Apr, 2023 | 13:24h | UTCMeta-Analysis of Glucocorticoids for Covid-19 Patients Not Receiving Oxygen – NEJM Evidence
Commentary on Twitter (thread – click for more)
4/
? IMPLICATIONS#Glucocorticoids are a two-edged sword in COVID-19 treatment ?️
? Life-saving for patients receiving #oxygen☠️ Harmful for patients not on oxygen
— San Raffaele Anesthesia and Intensive Care (@SRAnesthesiaICU) April 18, 2023
RCT | Prophylactic tranexamic acid in cesarean delivery did not significantly reduce maternal death or transfusion risk
19 Apr, 2023 | 13:22h | UTCTranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Tranexamic acid does not appear to prevent maternal hemorrhage after cesarean delivery – National Institutes of Health
Commentary on Twitter
In a placebo-controlled trial involving patients undergoing cesarean delivery, prophylactic use of tranexamic acid did not lead to a significantly lower risk of a composite outcome of maternal death or blood transfusion. https://t.co/iB3axZiVqw pic.twitter.com/RDFUsspIr0
— NEJM (@NEJM) April 12, 2023
RCT | Blood donor’s sex does not impact transfusion recipients’ survival
19 Apr, 2023 | 13:20h | UTCEffect of Donor Sex on Recipient Mortality in Transfusion – New England Journal of Medicine (link to abstract – $ for full-text)
News release: Sex of blood donor has no effect on recipient survival – Ottawa Hospital
Commentary on Twitter
Observational data are conflicting about whether donor sex influences mortality among transfusion recipients. In a multicenter trial in Canada involving 8719 patients, mortality was not influenced by blood-donor sex. https://t.co/54GKPXSXES pic.twitter.com/uYw1KT15py
— NEJM (@NEJM) April 12, 2023
Perspective | Here’s a new data point for cancer patients to consider: ‘time toxicity’
19 Apr, 2023 | 13:18h | UTCHere’s a new data point for cancer patients to consider: ‘time toxicity’ – STAT
Ischemia with nonobstructive coronary artery disease: concept, assessment, and management
19 Apr, 2023 | 13:17h | UTCRelated:
Review: Myocardial infarction with non-obstructive coronary artery disease.
MINOCA from A to Z – American College of Cardiology
M-A | Test characteristics of ultrasound for the diagnosis of peritonsillar abscess
19 Apr, 2023 | 13:15h | UTCCommentary: How Good is Ultrasound at Diagnosing PTA? – RebelEM
Global Survey | Incidence, management and prognosis of esophageal fistula after atrial fibrillation catheter ablation
19 Apr, 2023 | 13:14h | UTCCommentary: Esophageal Fistula Still a Rare but Deadly Complication of AF Ablation: POTTER-AF – TCTMD
Commentary from the author on Twitter
?The POTTER-AF study
➡️published #EHJ online
➡️138 oesophageal fistulas
➡️incidence 0,025% overall, ?RF 0.038%, ❄️CRYO 0.0015%
☠️Mortality: 90% if treated conservative!
?V. Schmidt, @KeelaniAhmad @ChristianHeeger@AGEP_DGK @ESC_Journals #UKSHhttps://t.co/jTmC36wlYQ #EPeeps pic.twitter.com/3lntY6lR6H— Roland Tilz (@RolandTilz) April 16, 2023
SR | Opioids for procedural pain in neonates
19 Apr, 2023 | 13:11h | UTCOpioids for procedural pain in neonates – Cochrane Library
Guideline | Management of psychiatric disorders in patients with hepatic and gastrointestinal diseases
19 Apr, 2023 | 13:07h | UTC
RCT | Small benefit from pembrolizumab + gemcitabine/cisplatin vs. gemcitabine/cisplatin alone in advanced biliary tract cancer
19 Apr, 2023 | 13:10h | UTCPembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
New @TheLancet – Kelley et al – Pembrolizumab plus gemcitabine and cisplatin vs gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966)https://t.co/ZbdRQwzSuW#gitwitter #onctwitter pic.twitter.com/PwoNAduQxK
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) April 18, 2023
Study suggests that routine axillary scanning in diagnostic breast ultrasound has limited impact on cancer detection
19 Apr, 2023 | 13:06h | UTCTo scan or not to scan: effect of scanning the axilla of all patients undergoing diagnostic breast ultrasound – Clinical Imaging (link to abstract – $ for full-text)
Commentary: Is scanning the axilla during diagnostic breast ultrasound necessary? – Health Imaging